VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $2.4 million in its second quarter.
The Victoria, British Columbia-based company said it had a loss of 3 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The biotechnology company posted revenue of $329,000 in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $56,000.
Aurinia shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.71, a climb of 39 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
Keywords: Aurinia Pharmaceuticals, Earnings Report